Regulation of glycogen synthase activity in cultured skeletal muscle cells from subjects with type II diabetes: role of chronic
hyperinsulinemia and hyperglycemia. Diabetes June 1997 46:1017-1024; doi:10.2337/diabetes.46.6.1017
Analysis of candidate genes for susceptibility to type I diabetes: a case-control and family-association study of genes on
chromosome 2q31-35. Diabetes June 1997 46:1069-1074; doi:10.2337/diabetes.46.6.1069
Impact of natural IRS-1 mutations on insulin signals: mutations of IRS-1 in the PTB domain and near SH2 protein binding sites
result in impaired function at different steps of IRS-1 signaling. Diabetes June 1997 46:929-936; doi:10.2337/diabetes.46.6.929
Modulatory effect of erythrocytes on the platelet reactivity to collagen in IDDM patients. Diabetes June 1997 46:1047-1053; doi:10.2337/diabetes.46.6.1047
Characterization of the unusual insulin of Psammomys obesus, a rodent with nutrition-induced NIDDM-like syndrome. Diabetes June 1997 46:953-957; doi:10.2337/diabetes.46.6.953
Modulatory effect of erythrocytes on the platelet reactivity to collagen in IDDM patients. Diabetes June 1997 46:1047-1053; doi:10.2337/diabetes.46.6.1047
B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes June 1997 46:941-946; doi:10.2337/diabetes.46.6.941
Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. Diabetes June 1997 46:1010-1016; doi:10.2337/diabetes.46.6.1010
Circulating leptin in normal children and during the dynamic phase of juvenile obesity: relation to body fatness, energy metabolism,
caloric intake, and sexual dimorphism. Diabetes June 1997 46:989-993; doi:10.2337/diabetes.46.6.989
D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells:
implications for diabetic nephropathy. Diabetes June 1997 46:1030-1039; doi:10.2337/diabetes.46.6.1030
Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. Diabetes June 1997 46:1010-1016; doi:10.2337/diabetes.46.6.1010
Treatment with neutralizing antibodies specific for IL-1beta prevents cyclophosphamide-induced diabetes in nonobese diabetic
mice. Diabetes June 1997 46:937-940; doi:10.2337/diabetes.46.6.937
Modulatory effect of erythrocytes on the platelet reactivity to collagen in IDDM patients. Diabetes June 1997 46:1047-1053; doi:10.2337/diabetes.46.6.1047
Treatment with neutralizing antibodies specific for IL-1beta prevents cyclophosphamide-induced diabetes in nonobese diabetic
mice. Diabetes June 1997 46:937-940; doi:10.2337/diabetes.46.6.937
Characterization of the unusual insulin of Psammomys obesus, a rodent with nutrition-induced NIDDM-like syndrome. Diabetes June 1997 46:953-957; doi:10.2337/diabetes.46.6.953
Regulation of glycogen synthase activity in cultured skeletal muscle cells from subjects with type II diabetes: role of chronic
hyperinsulinemia and hyperglycemia. Diabetes June 1997 46:1017-1024; doi:10.2337/diabetes.46.6.1017
Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. Diabetes June 1997 46:1010-1016; doi:10.2337/diabetes.46.6.1010
Novel insulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression. Diabetes June 1997 46:958-967; doi:10.2337/diabetes.46.6.958
D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells:
implications for diabetic nephropathy. Diabetes June 1997 46:1030-1039; doi:10.2337/diabetes.46.6.1030
Novel insulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression. Diabetes June 1997 46:958-967; doi:10.2337/diabetes.46.6.958
Circulating leptin in normal children and during the dynamic phase of juvenile obesity: relation to body fatness, energy metabolism,
caloric intake, and sexual dimorphism. Diabetes June 1997 46:989-993; doi:10.2337/diabetes.46.6.989
Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. Diabetes June 1997 46:1010-1016; doi:10.2337/diabetes.46.6.1010
Treatment with neutralizing antibodies specific for IL-1beta prevents cyclophosphamide-induced diabetes in nonobese diabetic
mice. Diabetes June 1997 46:937-940; doi:10.2337/diabetes.46.6.937
D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells:
implications for diabetic nephropathy. Diabetes June 1997 46:1030-1039; doi:10.2337/diabetes.46.6.1030
Novel insulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression. Diabetes June 1997 46:958-967; doi:10.2337/diabetes.46.6.958
D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells:
implications for diabetic nephropathy. Diabetes June 1997 46:1030-1039; doi:10.2337/diabetes.46.6.1030
Impact of natural IRS-1 mutations on insulin signals: mutations of IRS-1 in the PTB domain and near SH2 protein binding sites
result in impaired function at different steps of IRS-1 signaling. Diabetes June 1997 46:929-936; doi:10.2337/diabetes.46.6.929
Analysis of candidate genes for susceptibility to type I diabetes: a case-control and family-association study of genes on
chromosome 2q31-35. Diabetes June 1997 46:1069-1074; doi:10.2337/diabetes.46.6.1069
Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes June 1997 46:1001-1009; doi:10.2337/diabetes.46.6.1001
Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes June 1997 46:1001-1009; doi:10.2337/diabetes.46.6.1001
D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells:
implications for diabetic nephropathy. Diabetes June 1997 46:1030-1039; doi:10.2337/diabetes.46.6.1030
Characterization of the unusual insulin of Psammomys obesus, a rodent with nutrition-induced NIDDM-like syndrome. Diabetes June 1997 46:953-957; doi:10.2337/diabetes.46.6.953
Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic beta-cells. Diabetes June 1997 46:1087-1093; doi:10.2337/diabetes.46.6.1087
Novel insulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression. Diabetes June 1997 46:958-967; doi:10.2337/diabetes.46.6.958
Proinsulin conversion in GH3 cells after coexpression of human proinsulin with the endoproteases PC2 and/or PC3. Diabetes June 1997 46:978-982; doi:10.2337/diabetes.46.6.978
Polymorphisms in the interleukin-1 gene cluster do not contribute to the genetic susceptibility of diabetic nephropathy in
Caucasian patients with IDDM. Diabetes June 1997 46:1075-1076
Hansen, P
Novel insulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression. Diabetes June 1997 46:958-967; doi:10.2337/diabetes.46.6.958
Polymorphisms in the interleukin-1 gene cluster do not contribute to the genetic susceptibility of diabetic nephropathy in
Caucasian patients with IDDM. Diabetes June 1997 46:1075-1076
Heilig, C W
D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells:
implications for diabetic nephropathy. Diabetes June 1997 46:1030-1039; doi:10.2337/diabetes.46.6.1030
D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells:
implications for diabetic nephropathy. Diabetes June 1997 46:1030-1039; doi:10.2337/diabetes.46.6.1030
Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic beta-cells. Diabetes June 1997 46:1087-1093; doi:10.2337/diabetes.46.6.1087
Regulation of glycogen synthase activity in cultured skeletal muscle cells from subjects with type II diabetes: role of chronic
hyperinsulinemia and hyperglycemia. Diabetes June 1997 46:1017-1024; doi:10.2337/diabetes.46.6.1017
Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic beta-cells. Diabetes June 1997 46:1087-1093; doi:10.2337/diabetes.46.6.1087
Characterization of the unusual insulin of Psammomys obesus, a rodent with nutrition-induced NIDDM-like syndrome. Diabetes June 1997 46:953-957; doi:10.2337/diabetes.46.6.953
Proinsulin conversion in GH3 cells after coexpression of human proinsulin with the endoproteases PC2 and/or PC3. Diabetes June 1997 46:978-982; doi:10.2337/diabetes.46.6.978
Characterization of the unusual insulin of Psammomys obesus, a rodent with nutrition-induced NIDDM-like syndrome. Diabetes June 1997 46:953-957; doi:10.2337/diabetes.46.6.953
Impact of natural IRS-1 mutations on insulin signals: mutations of IRS-1 in the PTB domain and near SH2 protein binding sites
result in impaired function at different steps of IRS-1 signaling. Diabetes June 1997 46:929-936; doi:10.2337/diabetes.46.6.929
Proinsulin conversion in GH3 cells after coexpression of human proinsulin with the endoproteases PC2 and/or PC3. Diabetes June 1997 46:978-982; doi:10.2337/diabetes.46.6.978
B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes June 1997 46:941-946; doi:10.2337/diabetes.46.6.941
Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic beta-cells. Diabetes June 1997 46:1087-1093; doi:10.2337/diabetes.46.6.1087
Impact of natural IRS-1 mutations on insulin signals: mutations of IRS-1 in the PTB domain and near SH2 protein binding sites
result in impaired function at different steps of IRS-1 signaling. Diabetes June 1997 46:929-936; doi:10.2337/diabetes.46.6.929
Circulating leptin in normal children and during the dynamic phase of juvenile obesity: relation to body fatness, energy metabolism,
caloric intake, and sexual dimorphism. Diabetes June 1997 46:989-993; doi:10.2337/diabetes.46.6.989
Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. Diabetes June 1997 46:1010-1016; doi:10.2337/diabetes.46.6.1010
Circulating leptin in normal children and during the dynamic phase of juvenile obesity: relation to body fatness, energy metabolism,
caloric intake, and sexual dimorphism. Diabetes June 1997 46:989-993; doi:10.2337/diabetes.46.6.989
Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic beta-cells. Diabetes June 1997 46:1087-1093; doi:10.2337/diabetes.46.6.1087
D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells:
implications for diabetic nephropathy. Diabetes June 1997 46:1030-1039; doi:10.2337/diabetes.46.6.1030
Impact of natural IRS-1 mutations on insulin signals: mutations of IRS-1 in the PTB domain and near SH2 protein binding sites
result in impaired function at different steps of IRS-1 signaling. Diabetes June 1997 46:929-936; doi:10.2337/diabetes.46.6.929
Impact of natural IRS-1 mutations on insulin signals: mutations of IRS-1 in the PTB domain and near SH2 protein binding sites
result in impaired function at different steps of IRS-1 signaling. Diabetes June 1997 46:929-936; doi:10.2337/diabetes.46.6.929
Regulation of glycogen synthase activity in cultured skeletal muscle cells from subjects with type II diabetes: role of chronic
hyperinsulinemia and hyperglycemia. Diabetes June 1997 46:1017-1024; doi:10.2337/diabetes.46.6.1017
Proinsulin conversion in GH3 cells after coexpression of human proinsulin with the endoproteases PC2 and/or PC3. Diabetes June 1997 46:978-982; doi:10.2337/diabetes.46.6.978
B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes June 1997 46:941-946; doi:10.2337/diabetes.46.6.941
Analysis of candidate genes for susceptibility to type I diabetes: a case-control and family-association study of genes on
chromosome 2q31-35. Diabetes June 1997 46:1069-1074; doi:10.2337/diabetes.46.6.1069
Novel insulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression. Diabetes June 1997 46:958-967; doi:10.2337/diabetes.46.6.958
Polymorphisms in the interleukin-1 gene cluster do not contribute to the genetic susceptibility of diabetic nephropathy in
Caucasian patients with IDDM. Diabetes June 1997 46:1075-1076
Nikoulina, S E
Regulation of glycogen synthase activity in cultured skeletal muscle cells from subjects with type II diabetes: role of chronic
hyperinsulinemia and hyperglycemia. Diabetes June 1997 46:1017-1024; doi:10.2337/diabetes.46.6.1017
B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes June 1997 46:941-946; doi:10.2337/diabetes.46.6.941
B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes June 1997 46:941-946; doi:10.2337/diabetes.46.6.941
Novel insulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression. Diabetes June 1997 46:958-967; doi:10.2337/diabetes.46.6.958
Analysis of candidate genes for susceptibility to type I diabetes: a case-control and family-association study of genes on
chromosome 2q31-35. Diabetes June 1997 46:1069-1074; doi:10.2337/diabetes.46.6.1069
Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. Diabetes June 1997 46:1010-1016; doi:10.2337/diabetes.46.6.1010
Regulation of glycogen synthase activity in cultured skeletal muscle cells from subjects with type II diabetes: role of chronic
hyperinsulinemia and hyperglycemia. Diabetes June 1997 46:1017-1024; doi:10.2337/diabetes.46.6.1017
Polymorphisms in the interleukin-1 gene cluster do not contribute to the genetic susceptibility of diabetic nephropathy in
Caucasian patients with IDDM. Diabetes June 1997 46:1075-1076
Passa, P
Genetics of NIDDM in France: studies with 19 candidate genes in affected sib pairs. Diabetes June 1997 46:1062-1068; doi:10.2337/diabetes.46.6.1062
Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. Diabetes June 1997 46:1010-1016; doi:10.2337/diabetes.46.6.1010
Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes June 1997 46:1001-1009; doi:10.2337/diabetes.46.6.1001
Polymorphisms in the interleukin-1 gene cluster do not contribute to the genetic susceptibility of diabetic nephropathy in
Caucasian patients with IDDM. Diabetes June 1997 46:1075-1076
Powell, D R
Analysis of candidate genes for susceptibility to type I diabetes: a case-control and family-association study of genes on
chromosome 2q31-35. Diabetes June 1997 46:1069-1074; doi:10.2337/diabetes.46.6.1069
Novel insulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression. Diabetes June 1997 46:958-967; doi:10.2337/diabetes.46.6.958
Polymorphisms in the interleukin-1 gene cluster do not contribute to the genetic susceptibility of diabetic nephropathy in
Caucasian patients with IDDM. Diabetes June 1997 46:1075-1076
Rostami, S Y
B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes June 1997 46:941-946; doi:10.2337/diabetes.46.6.941
Treatment with neutralizing antibodies specific for IL-1beta prevents cyclophosphamide-induced diabetes in nonobese diabetic
mice. Diabetes June 1997 46:937-940; doi:10.2337/diabetes.46.6.937
Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. Diabetes June 1997 46:1010-1016; doi:10.2337/diabetes.46.6.1010
Modulatory effect of erythrocytes on the platelet reactivity to collagen in IDDM patients. Diabetes June 1997 46:1047-1053; doi:10.2337/diabetes.46.6.1047
Characterization of the unusual insulin of Psammomys obesus, a rodent with nutrition-induced NIDDM-like syndrome. Diabetes June 1997 46:953-957; doi:10.2337/diabetes.46.6.953
Impact of natural IRS-1 mutations on insulin signals: mutations of IRS-1 in the PTB domain and near SH2 protein binding sites
result in impaired function at different steps of IRS-1 signaling. Diabetes June 1997 46:929-936; doi:10.2337/diabetes.46.6.929
Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes June 1997 46:1001-1009; doi:10.2337/diabetes.46.6.1001
Characterization of the unusual insulin of Psammomys obesus, a rodent with nutrition-induced NIDDM-like syndrome. Diabetes June 1997 46:953-957; doi:10.2337/diabetes.46.6.953
Polymorphisms in the interleukin-1 gene cluster do not contribute to the genetic susceptibility of diabetic nephropathy in
Caucasian patients with IDDM. Diabetes June 1997 46:1075-1076
Tayber, O
Novel mutations and a mutational hotspot in the MODY3 gene. Diabetes June 1997 46:1081-1086; doi:10.2337/diabetes.46.6.1081
Impact of natural IRS-1 mutations on insulin signals: mutations of IRS-1 in the PTB domain and near SH2 protein binding sites
result in impaired function at different steps of IRS-1 signaling. Diabetes June 1997 46:929-936; doi:10.2337/diabetes.46.6.929
Analysis of candidate genes for susceptibility to type I diabetes: a case-control and family-association study of genes on
chromosome 2q31-35. Diabetes June 1997 46:1069-1074; doi:10.2337/diabetes.46.6.1069
Impact of natural IRS-1 mutations on insulin signals: mutations of IRS-1 in the PTB domain and near SH2 protein binding sites
result in impaired function at different steps of IRS-1 signaling. Diabetes June 1997 46:929-936; doi:10.2337/diabetes.46.6.929
Impact of natural IRS-1 mutations on insulin signals: mutations of IRS-1 in the PTB domain and near SH2 protein binding sites
result in impaired function at different steps of IRS-1 signaling. Diabetes June 1997 46:929-936; doi:10.2337/diabetes.46.6.929
Modulatory effect of erythrocytes on the platelet reactivity to collagen in IDDM patients. Diabetes June 1997 46:1047-1053; doi:10.2337/diabetes.46.6.1047
Modulatory effect of erythrocytes on the platelet reactivity to collagen in IDDM patients. Diabetes June 1997 46:1047-1053; doi:10.2337/diabetes.46.6.1047
Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. Diabetes June 1997 46:1010-1016; doi:10.2337/diabetes.46.6.1010
Treatment with neutralizing antibodies specific for IL-1beta prevents cyclophosphamide-induced diabetes in nonobese diabetic
mice. Diabetes June 1997 46:937-940; doi:10.2337/diabetes.46.6.937
Impact of natural IRS-1 mutations on insulin signals: mutations of IRS-1 in the PTB domain and near SH2 protein binding sites
result in impaired function at different steps of IRS-1 signaling. Diabetes June 1997 46:929-936; doi:10.2337/diabetes.46.6.929
Impact of natural IRS-1 mutations on insulin signals: mutations of IRS-1 in the PTB domain and near SH2 protein binding sites
result in impaired function at different steps of IRS-1 signaling. Diabetes June 1997 46:929-936; doi:10.2337/diabetes.46.6.929
D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells:
implications for diabetic nephropathy. Diabetes June 1997 46:1030-1039; doi:10.2337/diabetes.46.6.1030